Internal Medicine, General Medicine Conference-IPSC 2026

Respiratory conditions like chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis are commonly treated in internal medicine. These diseases call for early diagnosis, prophylaxis, and treatment strategies spanning a lifetime. Physicians aim to enhance lung function, minimize exacerbations, and improve quality of life through evidence-based practice.

Emerging treatments, such as biologics for asthma and antifibrotic drugs for pulmonary fibrosis, are providing new hope to sufferers. Programs for smoking cessation, pulmonary rehabilitation, and management of environmental exposure continue to be vital components of care. By integrating pharmacologic therapies with lifestyle modification, internal medicine physicians are meeting the entire range of pulmonary health issues.